Yahoo

Sonic Healthcare (ASX:SHL) Shares May Trade At A Discount On Earnings

Sonic Healthcare has seen its share price fall over several time frames, and that slump puts fresh focus on a simple question for investors. Are you now paying a price that is properly explained by what the company earns today and what those earnings can realistically support?

  • Over the past 5 years the stock has declined 43.1%, which makes the current share price far more about what the earnings profile looks like now than about past gains.

  • The business relies on converting medical testing volumes into consistent profit, so any change in how efficiently it turns revenue into earnings can heavily influence what a fair P/E might look like.

  • Your read on Sonic Healthcare is one view; the desks covering it have another. See what analysts think Sonic Healthcare's shares could be worth .

The issue now is whether Sonic Healthcare's current share price is adequately backed by its earnings when judged against the Fair Ratio benchmark.

If you are weighing Sonic Healthcare against alternatives that also focus on valuation discipline, it can help to compare it with companies from the 4 high quality undervalued stocks .

Does Sonic Healthcare Look Undervalued on Earnings?

The P/E works well for Sonic Healthcare because earnings sit at the center of how this business converts test volumes into value for shareholders. On this measure, the stock trades at about 15.1x earnings, which is below the healthcare sector average of roughly 19.5x and far under the peer group near 39.3x. For a reader, that means the market is currently pricing each dollar of Sonic Healthcare profit at a lower level than many similar companies in the same space.

The Fair Ratio, which reflects what a tailored P/E might look like once growth, profitability, size and risk are baked in, comes out higher than where Sonic Healthcare trades today. That places the current 15.1x multiple on the lower side of what this framework suggests might be appropriate, even after considering sector characteristics. For investors who care about valuation discipline, that gap points to a stock that screens as undervalued on earnings against this benchmark. Explore the numbers behind Sonic Healthcare's P/E valuation .

ASX:SHL P/E Ratio as at Oct 2026
ASX:SHL P/E Ratio as at Oct 2026

The Sonic Healthcare Narrative: What Would Justify Today's Price?

Narratives for Sonic Healthcare pick up where the P/E puzzle leaves off and spell out which paths for growth, margins and earnings would need to play out for the stock to be worth materially more or materially less than today's price, all hosted on Simply Wall St's Community page. Instead of a single valuation output, each scenario lays out its own set of assumptions so you can compare those inputs with Sonic Healthcare's actual results as they arrive.

One of the top community narratives on Sonic Healthcare: 38% undervalued

"By moving into specialized testing, Sonic reduces its reliance on commodity testing and positions itself in the high-growth segment of molecular diagnostics…"

Discover why this Narrative puts Sonic Healthcare at 38% undervalued .

One more Sonic Healthcare puzzle to check before you act

Before you lean too heavily on where Sonic Healthcare trades today, it is worth seeing how professional analysts currently map out its profit path a few years from now and how that compares with the present earnings multiple. Explore where analysts expect Sonic Healthcare to be in a few years .

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SHL.AX .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: